Search

everythinglearnresearchcommunity

for

Search:↓

The conference emphasized innovative solutions for global challenges, including disaster architecture, education, health, and economic impacts.

Sertoliform endometrioid carcinoma of the ovary, though rare, has a good prognosis when treated early.

A woman with Sheehan syndrome improved with hormone treatment.

The removed ovarian tumor was a rare type of blood vessel tumor that improved the patient's symptoms and hormone levels after surgery.

Early postmenopausal women often experience skin issues like vaginal dryness, swallowing difficulties, hair loss, and uncommonly, keratoderma and hirsutism, but many are unaware these are related to menopause.

The woman's rare combination of diseases suggests an unknown factor may predispose individuals to multiple endocrine diseases.

After chemotherapy for a gestational trophoblastic tumor, normal pregnancy rates are possible, but there's a slightly higher risk of the tumor reoccurring in future pregnancies.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

The Rotterdam Study aims to understand disease causes in the elderly and has found new risk factors and genetic influences on various conditions.

Gynecologists should provide comprehensive care for transgender patients, including mental health evaluation, hormone therapy, and surgical options, while monitoring for side effects and ensuring patient safety.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

Oral dutasteride and topical pimecrolimus can safely and effectively treat Frontal Fibrosing Alopecia, leading to significant hair regrowth.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

Male faces age with more wrinkles and hair loss, influenced by both body changes and environmental factors.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

The study found three different timing patterns of symptoms in women with premenstrual dysphoric disorder.

Women experience various skin issues at different life stages, requiring careful treatment and awareness.

Early medical support for transgender youth is important for their health, with low regret for gender-affirming hormone use and a need for knowledgeable care providers.

Finasteride improves heart function and repairs damage after heart attack in mice.

Testosterone therapy can modestly improve sexual function in menopausal women but should be used cautiously and is not recommended for routine measurement in sexual dysfunction or hirsutism.

Male pattern baldness is an unintended side effect of the body's use of androgens for muscle growth, especially in those genetically prone to it.

Postmenopausal women with hyperandrogenism didn't have better metabolic health even after their testosterone levels became normal.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Blood tests can detect ovarian Leydig cell tumors when scans don't, and surgery can confirm and treat these tumors.

A woman with Cushing's syndrome improved after surgery to remove a tumor causing the condition.

The woman's surgery lowered her testosterone and improved scalp hair loss but did not change her excessive body hair.

Women with a certain type of tumor had higher levels of pregnancy hormone and male hormones, which decreased after treatment.

Hair loss in postmenopausal women due to ovarian hyperthecosis is rare, but removing the ovaries can significantly improve the condition.

Irradiating the whole central nervous system can lead to over 50% of patients with cerebellar medulloblastoma surviving three years.

Hyperandrogenism increases heart disease risk in premenopausal women, but this risk is linked to obesity in postmenopausal women.